Ignite Creation Date:
2025-12-24 @ 9:37 PM
Ignite Modification Date:
2026-02-22 @ 1:34 AM
Study NCT ID:
NCT02084732
Status:
COMPLETED
Last Update Posted:
2019-11-13
First Post:
2014-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Sponsor:
Instituto Nacional de Cancerologia, Columbia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-07
First Submit QC Date:
None
Study First Post Date:
2014-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-12
Last Update Post Date:
2019-11-13
Last Update Post Date Type:
ACTUAL